Giuseppina Catanzaro
Overview
Explore the profile of Giuseppina Catanzaro including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
50
Citations
892
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
DAntonio F, Spinello Z, Bargiacchi L, Splendiani E, Rossi S, Masuelli L, et al.
Crit Rev Oncol Hematol
. 2025 Feb;
208:104650.
PMID: 39914569
Central nervous system (CNS) tumors represent the most frequent solid tumors among adolescents and children, and the leading cause of cancer-related death in men < 40 and women < 20...
2.
Gianno F, Miele E, Sabato C, Ferretti E, Minasi S, Buttarelli F, et al.
Biomedicines
. 2025 Jan;
13(1).
PMID: 39857696
Background/objectives: Astroblastoma is a rare glial neoplasm more frequent in young female patients, with unclear clinical behaviors and outcomes. The diagnostic molecular alteration is a rearrangement of the Meningioma 1...
3.
Bimonte V, Catanzaro G, Po A, Trocchianesi S, Besharat Z, Spinello Z, et al.
Endocrine
. 2023 Nov;
83(3):798-809.
PMID: 37979099
Purpose: Breast cancer (BC) is the most common malignancy that affects women, and it is, to date, their leading cause of death. Luminal A molecular subtype accounts for 40% of...
4.
Catanzaro G, Conte F, Trocchianesi S, Splendiani E, Bimonte V, Mocini E, et al.
Sci Rep
. 2023 Nov;
13(1):19496.
PMID: 37945677
Obesity is the main risk factor for many non-communicable diseases. In clinical practice, unspecific markers are used for the determination of metabolic alterations and inflammation, without allowing the characterization of...
5.
Citarella A, Besharat Z, Trocchianesi S, Autilio T, Verrienti A, Catanzaro G, et al.
Biomark Res
. 2023 Sep;
11(1):82.
PMID: 37726827
Medullary Thyroid Carcinoma (MTC) is a rare neuroendocrine tumour whose diagnosis includes evaluating calcitonin serum levels, which can present fluctuations unrelated to MTC. Here, we investigated circulating DNA fragmentation and...
6.
Trocchianesi S, Po A, Citarella A, Spinello Z, Rughetti A, Besharat Z, et al.
Biomed Pharmacother
. 2023 Jun;
164:114995.
PMID: 37301138
Medullary thyroid carcinoma (MTC) is a malignant tumor with challenging management. Multi-targeted kinase inhibitors (MKI) and tyrosine-kinase inhibitors (TKI) with high specificity for RET protein are approved for advanced MTC...
7.
Pecoraro M, Catanzaro G, Conte F, Besharat Z, Messina E, Laschena L, et al.
Eur Urol Oncol
. 2023 Jun;
7(1):73-82.
PMID: 37270379
Background: Prostate cancer (PCa) is the most diagnosed cancer in men, with an increasing need to integrate noninvasive imaging and circulating microRNAs beyond prostate-specific antigen for screening and early detection....
8.
Citarella A, Catanzaro G, Besharat Z, Trocchianesi S, Barbagallo F, Gosti G, et al.
Cancers (Basel)
. 2023 Mar;
15(5).
PMID: 36900263
Colorectal cancer (CRC) is a leading cause of cancer-related mortality and chemoresistance is a major medical issue. The epithelial-to-mesenchymal transition (EMT) is the primary step in the emergence of the...
9.
Abballe L, Spinello Z, Antonacci C, Coppola L, Miele E, Catanzaro G, et al.
Pharmaceutics
. 2023 Feb;
15(2).
PMID: 36839827
Primary malignant brain tumors are the most common solid neoplasm in childhood. Despite recent advances, many children affected by aggressive or metastatic brain tumors still present poor prognosis, therefore the...
10.
Ambroselli D, Masciulli F, Romano E, Catanzaro G, Besharat Z, Massari M, et al.
Nutrients
. 2023 Feb;
15(3).
PMID: 36771347
The definition of metabolic syndrome (MetS) has undergone several changes over the years due to the difficulty in establishing universal criteria for it. Underlying the disorders related to MetS is...